Home › Blood Cancers › Virginia › Charlottesville
Blood Cancers clinical trials in Charlottesville, VA
6 studies for Blood Cancers are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
- Quetzal Site 3, Charlottesville
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RecruitingPhase 3
- University of Virginia Health System ( Site 0035), Charlottesville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- University of Virginia Comprehensive Cancer Center, Charlottesville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- University of Virginia School of Medicine, Charlottesville
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
RecruitingPhase 1
- University of Virginia, Charlottesville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- University of Virginia, Charlottesville
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Baltimore, MD18 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Edison, NJ14 studies
- Philadelphia, PA14 studies
- Nashville, TN13 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia16 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Endometrial Cancer14 studies
- Lung Cancer13 studies
- Metastatic Cancer13 studies
- Heart Failure11 studies
- Ischemic Stroke10 studies
- Ovarian Cancer10 studies
- Colorectal Cancer10 studies
- Type 1 Diabetes9 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.